SELLAS Life Sciences Group Inc

-0.09 (-5.62%)
4:40:58 PM EDT: $1.52 +0.01 (+0.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)42.81M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$13 Million
Adjusted EPS$0.02
See more estimates
10-Day MA$1.52
50-Day MA$1.55
200-Day MA$1.93
See more pivots

SELLAS Life Sciences Group Inc Stock, NASDAQ:SLS

Times Square Tower, 7 Times Square, New York, New York 10036
United States of America
Phone: +1.646.200.5278
Number of Employees: 17


SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.